Welcome to our dedicated page for Sempra Energy SEC filings (Ticker: SREA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Sempra 5.75% Junior Subordinated Notes due 2079 (SREA) provides access to Sempra’s regulatory reports where this security is formally identified. In Sempra’s Form 8-K filings, SREA appears in the table of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 as “Sempra 5.75% Junior Subordinated Notes Due 2079, $25 par value,” with Sempra listed as the registrant and the New York Stock Exchange as the listing exchange.
Through this page, users can review Sempra’s current and historical filings that reference SREA, including reports on material events, financial results and regulatory developments. Recent 8-K filings discuss topics such as California Public Utilities Commission proposed decisions on cost of capital for Sempra’s utility subsidiaries, wildfire-related legislation affecting San Diego Gas & Electric Company, and transactions involving Sempra Infrastructure Partners. While these filings address Sempra’s broader business, they also confirm the ongoing registration and listing of SREA as part of Sempra’s capital structure.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of each document in plain language. When a new Sempra filing is posted to EDGAR, it can be surfaced here with a concise explanation of what changed and how it relates to Sempra’s securities, including SREA. Users can quickly identify filings that mention SREA in the securities registration tables and then drill into the full text for detailed review.
This page is useful for anyone analyzing how Sempra’s reported regulatory environment, risk factors and capital-related transactions intersect with its registered securities. By combining real-time EDGAR updates with AI-generated highlights, it helps make complex filings more accessible for research on the Sempra 5.75% Junior Subordinated Notes due 2079.
Sempra executive Dyan Z. Wold, Vice President, Controller and Chief Accounting Officer, reported two transactions in Sempra common stock on 01/02/2026. One transaction (code F) shows the disposition of 700.98 shares of common stock at $89.71 per share. A second transaction (code A) records the acquisition of 2,890 shares of common stock at $0 per share. Following these transactions, Wold directly beneficially owned 5,670.36 shares of Sempra common stock.
Sempra executive Caroline A. Winn reported stock and option activity involving Sempra (SRE) shares. On 01/02/2026, Winn had 2,442.76 shares of Sempra common stock disposed of at $89.71 per share, leaving her with 31,221.33 shares held directly and 11,164 shares held indirectly through a 401(k) savings plan as of that date.
On the same date, she received an employee stock option grant covering 60,429 shares of Sempra common stock at an exercise price of $89.71 per share, expiring on 01/01/2036. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.
Sempra’s Executive VP and CFO Karen L. Sedgwick reported a new equity award and related share activity. On 01/02/2026, she received an employee stock option to buy 70,418 shares of Sempra common stock at an exercise price of $89.71 per share. The option expires on 01/01/2036 and becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.
On the same date, Sedgwick reported the disposition of 953.98 shares of common stock at $89.71 per share. Following these transactions as of 01/02/2026, she beneficially owned 40,325.59 shares of Sempra common stock directly and 153.61 shares indirectly through a 401(k) savings plan, in addition to the newly granted option.
Sempra officer Lisa Larroque Alexander, SVP, Corporate Affairs and HR, reported common stock transactions dated 01/02/2026. She disposed of 1,489.96 shares of Sempra common stock at $89.71 per share and acquired 5,824 shares of common stock at a price of $0 per share on the same date. Following these transactions, she beneficially owned 15,658.88 shares of Sempra common stock, held as direct ownership.
Sempra insider Diana L. Day, Chief Legal Counsel, reported stock transactions dated 01/02/2026. The filing shows a disposition of 1,407.66 shares of common stock at $89.71 per share under transaction code "F", which typically relates to shares withheld to cover taxes. On the same date, she acquired 9,364 shares of common stock at $0 per share under transaction code "A", indicating a grant or vesting of equity compensation rather than an open‑market purchase.
Following these transactions, she beneficially owns 25,061.6 shares of Sempra common stock in direct ownership and 418.61 shares held indirectly through a 401(k) Savings Plan as of 01/02/2026.
Sempra executive Justin C. Bird, Executive Vice President, reported equity transactions in Sempra common stock. On 01/02/2026, he was granted an employee stock option to buy 93,349 shares of Sempra common stock at an exercise price of $89.71 per share. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.
The filing also reports a disposition of 916.88 shares of common stock at $89.71 per share, reported under transaction code F, typically used for shares withheld to cover taxes. After these transactions, Bird beneficially owns 19,401.71 shares directly and 4,689.07 shares indirectly through a 401(k) savings plan as of 01/02/2026.
Sempra’s chairman, CEO and president reported several open-market sales of company common stock and a large stock option grant. On 01/02/2026, he sold 2,394 and 27,606 shares of common stock at weighted average prices of $88.31 and $89.38 per share. On 01/05/2026, he sold 20,533, 2,278 and 300 shares at weighted average prices of $87.13, $87.74 and $88.93 per share. He also received an employee stock option to buy 343,856 shares of Sempra common stock at an exercise price of $89.71 per share, expiring on 01/01/2036. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant. He also reports indirect ownership through a 401(k) savings plan as of 01/02/2026.
Sempra insider files notice to sell common stock
A holder of Sempra common stock filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 23,111 shares of common stock through broker Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of $2,073,287.81. The shares were acquired on February 19, 2025 through the vesting of restricted stock units granted under Sempra’s Long-Term Incentive Plan as compensation.
The notice also reports that over the prior three months, Jeffrey W. Martin sold 30,000 shares of Sempra common stock on January 2, 2026 for gross proceeds of $2,678,887.77. The company’s common shares outstanding are stated as 652,681,521, providing context for the size of these transactions.
Sempra director reports phantom stock award
Director James C. Yardley reported receiving 139.34 phantom shares of Sempra common stock as director compensation at a derivative price of $89.71 per share on 01/02/2026. These phantom shares are a form of deferred equity-based compensation that track the value of Sempra common stock on a 1-for-1 basis. Following this transaction, Yardley beneficially owned a total of 40,656.7 phantom shares.
The total phantom share balance includes 1,892.82 unvested restricted phantom shares that can be forfeited if his service as a director ends before vesting for reasons other than death, disability or removal without cause. The phantom shares that have vested are immediately exercisable, and the instrument does not have an expiration date.
Sempra director Anya Weaving reported receiving phantom share-based director compensation. On 01/02/2026, she acquired 139.34 phantom shares of Sempra common stock at a derivative security price of $89.71 per phantom share. These phantom shares are convertible into Sempra common stock on a 1-for-1 basis, are immediately exercisable for vested shares, and have no stated expiration date. Following this transaction, she beneficially owns 658.51 phantom shares, held in direct form.